OpenBilldrug price receipt

NADAC week of 2026-10-14

TROSPIUM CHLORIDE 20 MG TABLET

For 30 tablets

Pharmacies pay

$6.34 filed

30 × $0.21142 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$17.86 filed

30 × $0.59533 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

2.8× estimated

Medicare paid 2.8× what pharmacies pay.

Part D averages every strength and form sold under “Trospium Chloride” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$12.29 estimated

$6.34 + $0.95 (15%) + $5.00 fee per fill = $12.29

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

TROSPIUM CHLORIDE 20 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as trospium chloride.

FDA gives its dosage form as “tablet, film coated” and “tablet” and its route as oral.

FDA lists 9 labelers (the companies named on the label) for its NDCs, among them Padagis US LLC, Major Pharmaceuticals and Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.

FDA’s Established Pharmacologic Class for it is Cholinergic Muscarinic Antagonist.

The NADAC file of 2026-10-14 prices it under 11 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $6.34 for 30 tablets (30 × $0.21142 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 9 labelers

LabelerNDCsPharmacies pay per unit
Glenmark Pharmaceuticals Inc., USA2$0.21142 per EA filed
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.2$0.21142 per EA filed
CIPLA USA INC.,1$0.21142 per EA filed
Chartwell RX, LLC1$0.21142 per EA filed
Exelan Pharmaceuticals Inc.1$0.21142 per EA filed
Macleods Pharmaceuticals Limited1$0.21142 per EA filed
Major Pharmaceuticals1$0.21142 per EA filed
Padagis US LLC1$0.21142 per EA filed
Zameer Pharmaceuticals LLC1$0.21142 per EA filed
All 11 NDCs, with labeler and price
  • 00574-0145-60 · Padagis US LLC · $0.21142 per EA · eff. 2026-09-23 filed
  • 00904-7059-52 · Major Pharmaceuticals · $0.21142 per EA · eff. 2026-09-23 filed
  • 23155-0530-05 · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. · $0.21142 per EA · eff. 2026-09-23 filed
  • 23155-0530-06 · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. · $0.21142 per EA · eff. 2026-09-23 filed
  • 33342-0554-09 · Macleods Pharmaceuticals Limited · $0.21142 per EA · eff. 2026-09-23 filed
  • 62135-0742-60 · Chartwell RX, LLC · $0.21142 per EA · eff. 2026-09-23 filed
  • 68462-0461-10 · Glenmark Pharmaceuticals Inc., USA · $0.21142 per EA · eff. 2026-09-23 filed
  • 68462-0461-60 · Glenmark Pharmaceuticals Inc., USA · $0.21142 per EA · eff. 2026-09-23 filed
  • 69097-0912-03 · CIPLA USA INC., · $0.21142 per EA · eff. 2026-09-23 filed
  • 76282-0336-60 · Exelan Pharmaceuticals Inc. · $0.21142 per EA · eff. 2026-09-23 filed
  • 90096-0141-60 · Zameer Pharmaceuticals LLC · $0.21142 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

1 other product in the NADAC file shares the FDA nonproprietary name trospium chloride with TROSPIUM CHLORIDE 20 MG TABLET.

ProductPharmacies pay per unitMedicare per unit
TROSPIUM CHLORIDE 20 MG TABLET this page
generic · tablet, film coated / tablet
$0.21142 per EA filed
eff. 2026-09-23
$0.59533 per EA filed
Part D 2024 average
TROSPIUM CHLORIDE ER 60 MG CAP
generic · capsule, extended release
$1.64301 per EA filed
eff. 2026-09-23
$3.22773 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 11 NDCs’ NADAC prices is $0.21142 per EA filed.

Of the 25 other products in FDA’s Cholinergic Muscarinic Antagonist class priced per EA, 15 have a higher middle NADAC price and 10 a lower one. The one in the middle is TOLTERODINE TART ER 2 MG CAP, at $0.2678 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $17.86 for 30 tablets, at an average of $0.59533 per EA in 2024 (2024-01-01 to 2024-12-31) for “Trospium Chloride”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 448,238 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for TROSPIUM CHLORIDE 20 MG TABLET labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Trospium Chloride / Trospium Chloride: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.